HLA-F and glioma: Then, we evaluated the survival time of each group and found that the patients with higher HLA-F expression have remarkably shorter OS in all grade gliomas and GBM in the CGGA RNA-seq set (Fig. 4a, b; p < 0.0001 for all grade gliomas, p = 0.0587 for GBM).